Skip to main content
Hemoglobin Oxygen Therapeutics LLC (HOTI)
Hemoglobin Oxygen Therapeutics LLC will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

HOTI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 TTM Dec '21 Dec '20
Selling, General & Admin
2.672.672.67
Research & Development
0.770.770.57
Operating Expenses
3.443.443.25
Operating Income
-3.44-3.44-3.21
Interest Expense / Income
-0.68-0.68-0.38
Other Expense / Income
3.373.370.76
Pretax Income
-6.13-6.13-3.59
Net Income
-6.13-6.13-3.59
Free Cash Flow
-1.91-1.91-0.98
EBITDA
-6.21-6.21-3.42
Depreciation & Amortization
0.60.60.55
EBIT
-6.81-6.81-3.97
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).